Schedule 13G ownership disclosure
CUE BIOPHARMA INC
Common Stock, par value $0.001 per share · CUSIP: 22978P106
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bleichroeder LP
Shares: 663,009 · Class: 8.77%
- Bleichroeder Holdings LLC
Shares: 663,009 · Class: 8.77%
- Andrew Gundlach
Shares: 663,009 · Class: 8.77%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001420506-26-002561
- Form type
- SCHEDULE 13G/A
- Filer
- Bleichroeder LP
- CIK
- CIK 1781002
- Filed
- Nov 10, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership